2100 Smithtown Avenue,
Ronkonkoma, New York 11779
(Address of principal executive offices) (Zip Code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ý NO o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES o NO ý

The number of shares of Common Stock (par value $.008 per share) outstanding as of January 30, 2009 was 61,600,267.

NBTY, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(in thousands, except per share amounts)

			December 31, 2008			September 30, 2008

Assets
Current assets:
	Cash and cash equivalents		$	52,698		$	90,180
	Accounts receivable, net			139,856			122,878
	Inventories			608,354			585,239
	Deferred income taxes			25,355			25,098
	Other current assets			49,692			75,971

		Total current assets		875,955			899,366
Property, plant and equipment, net				399,428			419,066
Goodwill				324,064			342,379
Intangible assets, net				222,502			230,424
Other assets				38,390			45,123

		Total assets	$	1,860,339		$	1,936,358

Liabilities and Stockholders' Equity
Current liabilities:
	Current portion of long-term debt		$	32,575		$	33,309
	Accounts payable			134,981			120,620
	Accrued expenses and other current liabilities			169,085			172,035

		Total current liabilities		336,641			325,964
Long-term debt, net of current portion				501,960			538,402
Deferred income taxes				32,631			49,139
Other liabilities				32,632			24,657

		Total liabilities		903,864			938,162

Commitments and contingencies
Stockholders' equity:
	Common stock, $.008 par; authorized 175,000 shares; issued and outstanding 61,600 shares and 61,599 shares at December 31, 2008 and September 30, 2008, respectively			493			493
	Capital in excess of par			141,698			140,990
	Retained earnings			852,543			839,068
	Accumulated other comprehensive (loss) income			(38,259	)		17,645

		Total stockholders' equity		956,475			998,196

		Total liabilities and stockholders' equity	$	1,860,339		$	1,936,358

The accompanying notes are an integral part of these condensed consolidated financial statements.

NBTY, Inc.

Condensed Consolidated Statements of Income

(Unaudited)

(in thousands, except per share amounts)

			Three months ended December 31,

			2008			2007
Net sales			$	660,552		$	510,858

Costs and expenses:
	Cost of sales			388,503			240,331
	Advertising, promotion and catalog			31,291			34,169
	Selling, general and administrative			195,901			168,123
	IT project termination costs			8,647			—

				624,342			442,623

Income from operations				36,210			68,235

Other income (expense):
	Interest			(9,489	)		(3,862	)
	Miscellaneous, net			(5,633	)		4,887

				(15,122	)		1,025

Income before provision for income taxes				21,088			69,260
Provision for income taxes				7,613			23,438

		Net income	$	13,475		$	45,822

Net income per share:
	Basic		$	0.22		$	0.68
	Diluted		$	0.21		$	0.67
Weighted average common shares outstanding:
	Basic			61,600			66,903
	Diluted			63,114			68,786

The accompanying notes are an integral part of these condensed consolidated financial statements.

NBTY, Inc.

Condensed Consolidated Statements of Stockholders' Equity and Comprehensive (Loss) Income

Three Months Ended December 31, 2008 and 2007

(Unaudited)

(in thousands)

		Common Stock

		Common Stock												Accumulated Other Comprehensive (Loss) Income
		Number of Shares			Amount			Capital in Excess of Par			Retained Earnings			Accumulated Other Comprehensive (Loss) Income			Total Stockholders' Equity
Balance, September 30, 2008			61,599		$	493		$	140,990		$	839,068		$	17,645		$	998,196
Components of comprehensive income:
	Net income											13,475						13,475
	Foreign currency translation adjustment and other, net of taxes														(49,781	)		(49,781	)
	Change in fair value of interest rate swaps, net of taxes														(6,123	)		(6,123	)

Comprehensive loss:																	$	(42,429	)

Exercise of stock options			1						6									6
Stock compensation									702									702

Balance, December 31, 2008			61,600		$	493		$	141,698		$	852,543		$	(38,259	)	$	956,475

Balance, September 30, 2007			67,118		$	537		$	143,244		$	864,852		$	47,337		$	1,055,970
Components of comprehensive income:
	Net income											45,822						45,822
	Foreign currency translation adjustment and other, net of taxes														(4,399	)		(4,399	)

Comprehensive income:																	$	41,423

Adoption of FIN 48												(3,025	)					(3,025	)
Purchase and retirement of treasury shares			(296	)		(2	)		(468	)		(10,133	)					(10,603	)
Excess tax benefit from exercise of stock options									88									88

Balance, December 31, 2007			66,822		$	535		$	142,864		$	897,516		$	42,938		$	1,083,853

The accompanying notes are an integral part of these condensed consolidated financial statements.

NBTY, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(in thousands)

					Three months ended December 31,

					2008			2007
Cash flows from operating activities:
	Net income				$	13,475		$	45,822
	Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities:
		Impairments and disposals of property, plant and equipment				487			462
		Depreciation and amortization				17,521			13,932
		IT project termination costs				4,667			—
		Foreign currency transaction loss (gain)				5,886			(1,299	)
		Amortization of deferred charges				316			186
		Stock-based compensation				702			—
		Allowance for doubtful accounts				1,361			(229	)
		Inventory reserves				1,737			1,061
		Deferred income taxes				152			449
		Excess income tax benefit from exercise of stock options				—			(88	)
		Changes in operating assets and liabilities, net of acquisitions:
			Accounts receivable			(27,740	)		(11,789	)
			Inventories			(44,047	)		(7,784	)
			Other assets			4,698			785
			Accounts payable			24,613			687
			Accrued expenses and other liabilities			2,884			7,842

				Net cash provided by operating activities		6,712			50,037

Cash flows from investing activities:
	Purchase of property, plant and equipment					(22,639	)		(9,814	)
	Purchase of available-for-sale investments					—			(55,148	)
	Proceeds from sale of available-for-sale investments					—			39,272
	Cash paid for acquisitions, net of cash acquired					(264	)		(5,072	)
	Escrow refund, net of purchase price adjustments					12,219			—

				Net cash used in investing activities		(10,684	)		(30,762	)

Cash flows from financing activities:
	Principal payments under long-term debt agreements and capital leases					(8,497	)		(239	)
	Proceeds from borrowings under the Revolving Credit Facility					35,000			—
	Principal payments under the Revolving Credit Facility					(60,000	)		—
	Excess income tax benefit from exercise of stock options					—			88
	Proceeds from stock options exercised					6			—
	Purchase of treasury stock (subsequently retired)					—			(10,603	)

				Net cash used in financing activities		(33,491	)		(10,754	)

Effect of exchange rate changes on cash and cash equivalents						(19	)		(2,482	)

Net (decrease) increase in cash and cash equivalents						(37,482	)		6,039
Cash and cash equivalents at beginning of period						90,180			92,902

Cash and cash equivalents at end of period					$	52,698		$	98,941

The accompanying notes are an integral part of these condensed consolidated financial statements.

NBTY, Inc.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

(in thousands, except per share amounts)

NBTY, Inc. (together with its subsidiaries, "we," "our," "us," "NBTY," or the "Company") is a leading global vertically integrated manufacturer, marketer, distributor and retailer of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. We market over 25,000 products under numerous owned and private-label brands, including Nature's Bounty®, Vitamin World®, Pure Protein®, Body Fortress®, Puritan's Pride®, Holland & Barrett®, Rexall®, Osteo-Bi-Flex®, Flex-A-Min®, Knox®, Sundown®, MET-Rx®, WORLDWIDE Sport Nutrition®, American Health®, DeTuinen®, Le Naturiste™, SISU®, Solgar®, Physiologics® and Ester-C®.

We have prepared these financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") applicable to interim financial information and on a basis that is consistent with the accounting principles applied in our Annual Report on Form 10-K for the fiscal year ended September 30, 2008 ("2008 Form 10-K"). In our opinion, these financial statements reflect all adjustments (including normal recurring items) necessary for a fair presentation of our results for the interim periods presented. These financial statements do not include all information or notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with GAAP. Accordingly, these financial statements should be read in conjunction with the financial statements and notes thereto contained in our 2008 Form 10-K. Results for interim periods are not necessarily indicative of results which may be achieved for a full year.

The preparation of financial statements in conformity with GAAP requires that we make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. These judgments can be subjective and complex, and consequently actual results could differ materially from those estimates and assumptions. We base our estimates on historical experience and on various other assumptions we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Our most significant estimates include: sales returns and other allowances; inventory valuation and obsolescence; valuation and recoverability of long-lived assets, including goodwill; income taxes; and accruals for the outcome of current litigation.

In March 2008, the Financial Accounting Standards Board ("FASB") issued Statement of Financial Accounting Standards ("SFAS") No. 161, "Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133" ("SFAS 161"). SFAS 161 requires enhanced disclosures regarding an entity's derivative and hedging activities. These enhanced disclosures include information regarding how and why an entity uses derivative instruments; how derivative instruments and related hedge items are accounted for under SFAS 133, "Accounting for Derivative Instruments and Hedging Activities", and its related interpretations; and how derivative instruments and related hedge items affect an entity's financial position, financial performance and cash flows. SFAS 161 will become effective for us on October 1, 2009. The adoption of SFAS 161 will not have a material impact on our financial position, results of operations or liquidity.

In December 2007, the FASB issued SFAS No. 141 (revised 2007), ("SFAS 141R"), "Business Combinations", which replaces SFAS No. 141. The statement retains the purchase method of accounting for acquisitions, however, includes changes in the way assets and liabilities are recognized in purchase accounting. It also changes the recognition of assets acquired and liabilities assumed arising from contingencies, requires the capitalization of in-process research and development at fair value, and requires the expensing of acquisition-related costs as incurred. SFAS 141R will become effective for us beginning October 1, 2009 and will apply prospectively to business combinations completed on or after that date. The impact of the adoption of SFAS 141R will be dependent on the extent and nature of any future acquisitions.

In February 2007, the FASB issued SFAS No. 159, "The Fair Value Option for Financial Assets and Financial Liabilities" ("SFAS 159"). SFAS 159 permits companies to choose to measure certain financial instruments and other eligible items at fair value when the items are not otherwise currently required to be measured at fair value. Under SFAS 159, the decision to measure items at fair value is made at specified election dates on an irrevocable instrument-by-instrument basis. Companies electing the fair value option would be required to recognize changes in fair value in earnings and to expense upfront cost and fees associated with the item for which the fair value option is elected. Companies electing the fair value option are required to distinguish, on the face of the statement of financial position, the fair value of assets and liabilities for which the fair value option has been elected and similar assets and liabilities measured using another measurement attribute. SFAS 159 became effective for us on October 1, 2008. The adoption of SFAS 159 did not have a significant impact on our consolidated financial position or results of operations as we did not elect the fair value option.

In September 2006, the FASB issued SFAS No. 157, "Fair Value Measurements" ("SFAS 157"). SFAS 157 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and enhances disclosures about fair value measurements. SFAS 157 applies when other accounting pronouncements require fair value measurements; it does not require new fair value measurements. We adopted SFAS 157 on October 1, 2008 for financial assets and liabilities carried at fair value and non financial assets and liabilities that are recognized or disclosed on a recurring basis. The adoption did not have a material effect on the consolidated financial statements. In February 2008, the FASB issued FASB Staff Position 157-2, which provides for a one-year deferral of the provisions of SFAS 157 for non-financial assets and liabilities that are recognized or disclosed at fair value in the

consolidated financial statements on a non-recurring basis. FASB Staff Position 157-2 will become effective for us beginning October 1, 2009. We anticipate that the adoption of FASB Staff Position SFAS 157-2 will not have a significant impact on our consolidated financial position or results of operations.

On July 14, 2008, we acquired substantially all the nutritional supplement assets of Leiner Health Products Inc. ("Leiner") plus the assumption of certain liabilities for $370,600 (subject to adjustment based upon finalization of working capital balances acquired at the date of closing). During December 2008, the working capital balances were finalized resulting in an additional payment by us of $2,366 which increased goodwill. The working capital payment was made from the $15,000 held in escrow and the remainder of the escrow was returned to NBTY. The purchase price was funded primarily by the use of our existing $325,000 revolving credit facility and cash on hand. The Company also incurred $3,470 of direct transaction costs for a total purchase price of $376,436. Substantially all the goodwill associated with this acquisition is deductible for tax purposes.

At the closing of the Leiner acquisition, we anticipated workforce reductions and, as such, included an estimated accrual for such reductions of $5,508, comprised of severance and employee benefits, in the purchase price allocation. The rollforward of the workforce reduction accrual was as follows:

During the first quarter of fiscal 2009, we incurred $1,514 for severance costs, in the form of stay-bonuses, expected to be paid to Leiner transitional associates upon their termination. This amount was included in selling, general and administrative expense in the consolidated statement of income for the three months ended December 31, 2008.

The following unaudited pro forma financial information presents a summary of our consolidated net sales and net income for the three months ended December 31, 2007, assuming that the acquisition of Leiner had taken place on October 1, 2007:

The above unaudited pro forma financial information has been prepared for comparative purposes only and includes certain adjustments to actual financial results, such as imputed interest costs, and estimated additional depreciation and amortization expense as a result of property, plant and equipment and intangible assets acquired. The pro forma financial information does not purport to be indicative of the results of operations that would have been achieved had the acquisition taken place on the date indicated or that may result in the future.

On September 16, 2008, our subsidiary, NBTY Europe Limited, acquired Julian Graves, a UK independent retailer of nuts, seeds and confectionaries for approximately $25,000. Julian Graves has a network of 346 stores throughout the UK. The preliminary allocation of net assets acquired primarily consisted of inventory, property, plant and equipment, goodwill and other intangible assets. Since we acquired the outstanding share capital of Julian Graves, the goodwill associated with this acquisition is not deductible for tax purposes. The purchase agreement stipulates an adjustment to the purchase price between the buyer and seller for the excess or shortfall of the final working capital threshold as stated in the agreement. During January 2009, the final working capital amount was agreed between the buyer and seller, which will result in a reduction of the purchase price and goodwill of approximately $2,750 upon settlement. The allocation of net assets acquired is based on preliminary estimates. Finalization of the valuation of the net assets acquired and working capital balance at the date of closing are subject to change during the purchase price allocation period (generally one year from the acquisition date).

In September 2008, the UK Office of Fair Trading commenced an investigation under the merger control provisions of the Enterprise Act 2002 into the completed acquisition by NBTY Europe of Julian Graves. The investigation is ongoing. If the Office of Fair Trading concludes that there is a realistic prospect that the acquisition of Julian Graves will substantially lessen competition in the UK,

or a substantial part of the UK, it will either refer the acquisition for a further investigation by the Competition Commission or accept undertakings from NBTY Europe in lieu thereof. In the event of an adverse finding by the Competition Commission, NBTY Europe may be required to offer undertakings to resolve the competition concerns identified. Undertakings could include divestment of all or some of the acquired Julian Graves stores. Pending the outcome of the investigation, NBTY Europe has not integrated the Julian Graves business with its existing UK operations.

Proforma financial information related to Julian Graves is not provided as its impact was not material to our consolidated financial statements.

The changes in the carrying amount of goodwill by segment for the three month period ended December 31, 2008, were as follows:

The purchase price adjustments included in the Wholesale/US Nutrition segment relate to Leiner acquisition adjustments of $2,366 for the finalization of working capital balances, $730 of additional transaction costs and a $2,549 increase in the tax accrual. The purchase price adjustments included in the European Retail segment relate to the acquisition of Julian Graves.

The carrying amounts of intangible assets as of December 31, 2008 and September 30, 2008 were as follows:

		December 31, 2008				September 30, 2008

		Gross carrying amount		Accumulated amortization		Gross carrying amount		Accumulated amortization		Amortization period (years)
Definite lived intangible assets
Brands		$	97,124	$	22,356	$	98,566	$	21,374	20
Customer lists			64,903		40,739		65,007		39,882	2–15
Private label and customer relationships			121,622		9,355		123,435		8,068	10–20
Trademarks and licenses			15,547		6,477		17,308		6,847	2–20
Covenants not to compete			3,519		3,086		3,545		3,066	3–5

			302,715		82,013		307,861		79,237
Indefinite lived intangible asset
Trademark			1,800		—		1,800		—

	Total intangible assets	$	304,515	$	82,013	$	309,661	$	79,237

Aggregate amortization expense of other intangible assets included in the consolidated statements of income under the caption "selling, general and administrative" expenses for the three months ended December 31, 2008 and 2007 was approximately $4,035 and $3,381, respectively.

Assuming no changes in our definite lived intangible assets, estimated amortization expense for each of the five succeeding fiscal years is as follows:

During December 2008, management determined that certain information technology projects relating to the Direct Response/E-Commerce segment which were ineffective and not economical would be terminated. These newly purchased and partially installed Internet and computer programs were ineffective in generating new customers and were discontinued. As a result, $4,667 of previously capitalized software costs were written-off during the quarter. In addition, certain termination payments and future lease obligations of $3,415 were charged to operations during the quarter relating to these terminated projects as they will not provide any future economic benefit. As a result of the termination of operating management in the Direct Response/E-Commerce segment, we also incurred severance costs of $565.

The components of accrued expenses and other current liabilities were as follows:

			December 31, 2008		September 30, 2008

Credit Agreement:
	$300 million, five-year term loan		$	292,500	$	300,000
	Revolving Credit Facility			35,000		60,000
Senior Subordinated Notes				188,744		188,708
Multi-currency Term Loan				13,877		17,222
Mortgage				1,462		1,599
Capital Leases				2,952		4,182

				534,535		571,711
		Less: current portion		32,575		33,309

		Total	$	501,960	$	538,402

On July 25, 2002, a putative consumer class-action lawsuit was filed in California state court against our subsidiary, MET-Rx USA, Inc. ("MET-Rx"), claiming that the advertising and marketing of certain prohormone supplements were false and misleading, or alternatively, that the prohormone products contained ingredients that were controlled substances under California law. In February 2008, the court denied plaintiffs' motion for class certification. Plaintiffs appealed that ruling but have since abandoned the appeal.

In March 2004, a putative class-action lawsuit was filed in New Jersey against MET-Rx, claiming that the advertising and marketing of certain prohormone supplements were false and misleading and that plaintiff and the putative class of New Jersey purchasers of these products were entitled to damages and injunctive relief. Because these allegations are virtually identical to allegations made in a putative nationwide class-action previously filed in California, we moved to dismiss or stay the New Jersey action pending the outcome of the California action. The motion was granted, and the New Jersey action is stayed at this time.

Our subsidiary, Rexall Sundown, Inc. ("Rexall"), and certain of its subsidiaries are defendants in a class-action lawsuit brought in 2002 on behalf of all California consumers who bought various nutrition bars. Plaintiffs allege misbranding of nutrition bars and violations of California unfair competition statutes, misleading advertising and other similar causes of action. Plaintiffs seek restitution, legal fees and injunctive relief. We have defended this action vigorously. In December 2007, while Rexall's and the other defendants' renewed motion for judgment on the pleadings was pending, the Court again stayed the case for all purposes, pending rulings on other relevant cases before the California Supreme Court. The California Supreme Court issued a ruling in those other cases on February 11, 2008. The parties to those other cases filed a petition for certiorari with the United States Supreme Court. That petition was denied on January 12, 2009. The case remains stayed. Based upon the information currently available, no determination can be made at this time as to the final outcome of this case, nor can its materiality be accurately ascertained.

In addition to the foregoing, other regulatory inquiries, claims, suits and complaints (including product liability and intellectual property claims) arise in the ordinary course of our business. We believe that such other inquiries, claims, suits and complaints would not have a material adverse effect on our consolidated financial condition or results of operations, if adversely determined against us.

to utilize state tax credits that expire between 2013 and 2016. Therefore, our overall effective income tax rate could vary as a result of these factors.

The effective income tax rate for the three months ended December 31, 2008 and 2007 was 36.1% and 33.8%, respectively. The effective income tax rate was higher for the three months ended December 31, 2008 as compared to the prior comparable period due to a higher effective state rate as a result of increased operations in California from the Leiner acquisition.

We accrue interest and penalties related to unrecognized tax benefits in income tax expense. This methodology is consistent with previous periods. At December 31, 2008, we had $1,914 and $898 accrued for the potential payment of interest and penalties, respectively. As of December 31, 2008, we were subject to U.S. Federal Income Tax examinations for the tax years 2005-2008, and to non-US examinations for the tax years of 2003–2008. In addition, we are generally subject to state and local examinations for fiscal years 2005–2008.

Basic net income per share is based on the weighted average number of common shares outstanding during the three month period ended December 31, 2008 and 2007. Diluted net income per share includes the dilutive effect of outstanding stock options, which resulted in a dilutive effect of approximately 1,514 and 1,883 shares for the three months ended December 31, 2008 and 2007, respectively. There were 900 outstanding stock options at December 31, 2008 that were not included in the calculation of diluted net income per share since they would have been anti-dilutive.

On October 1, 2008, we adopted the provisions of SFAS 157, which establishes a framework for measuring fair value and expands disclosures about fair value measurements. SFAS 157 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. SFAS 157 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

In Fiscal 2008, we entered into two interest rate swap contracts to hedge the variability of future interest relating to a portion of the interest payments on our Term Loan. Each swap contract has a notional amount of $100 million and a fixed interest rate, before bank margin of 3.88% for a two year term and 4.195% for a three year term, respectively. Under the terms of the swap contracts, variable interest payments for a portion of our Term Loan are swapped for fixed interest payments.

In accordance with SFAS 133, as amended by SFAS 138, we have formally documented the relationship between the interest rate swap contracts and the Term Loan, as well as our risk management objective and strategy for undertaking the hedge transactions. This process includes linking the derivative which was designated as a cash flow hedge to the specific liability on the balance sheet. We record the change in the fair value of the swap contracts through Other Comprehensive Income ("OCI"), net of tax. Since we expect these hedging relationships to be highly effective, both at inception of the hedges and on an ongoing basis, they are expected to be highly effective in achieving offsetting changes in fair value attributable to the hedged risk during the period that the hedges are designated. We have determined that there will be no ineffectiveness in the hedging relationships since the hedged forecasted interest payments are based on the same notional amount, have the same reset dates, and are based on the same benchmark interest rate designated under the variable rate Term Loan. We assess, at the inception of the hedges and on an ongoing basis, whether the derivatives used in the hedging transaction are highly effective in offsetting changes in the cash flows of the hedged item. The change in the fair value of the swap contracts for the three months ended December 31, 2008 recorded through OCI, net of tax was $6,123. At December 31, 2008, the swap contracts liability, included in other liabilities, was $12,191. The fair value of the swap contracts were valued using observable current market information such as the prevailing LIBOR interest rate and LIBOR yield curve rates (Level 2).

The face value and the fair value of the 7¹/8% Senior Subordinated Notes at December 31, 2008, was $190,000 and $133,000, respectively. The fair value of the 7¹/8% Senior Subordinated Notes were valued based on then quoted market prices (Level 1).

Financial instruments which potentially subject us to credit risk consist primarily of cash and cash equivalents (the amounts of which may, at times, exceed Federal Deposit Insurance Corporation limits on insurable amounts), investments and trade accounts receivable. We mitigate our risk by investing in or through major financial institutions. At December 31, 2008, we had $3,075 of municipal auction rate securities, which were classified in non-current assets as available-for-sale investments.

We perform on-going credit evaluations of our customers and adjust credit limits based upon payment history and the customers' current credit worthiness, as determined by review of their current credit information. Customers account activity is continuously monitored. As a result of this review process, we record bad debt expense, which is based upon historical experience as well as specific customer collection issues that have been identified, to adjust the carrying amount of the related receivable to its estimated realizable value. While such bad debt expenses have historically been within expectations and allowances established, if the financial condition of one or more of our customers were to deteriorate, additional bad debt provisions may be required.

The following individual customers accounted for the following percentages of net sales for the three months ended December 31, 2008 and 2007, respectively:

The loss of any one of these customers, or any other major customer, would have a material adverse effect on our consolidated results of operations if we were unable to replace such customer(s).

The following individual customers accounted for 10% or more of the Wholesale/US Nutrition segment's gross accounts receivable as of December 31, 2008 and September 30, 2008, respectively:

We are organized by sales segments on a worldwide basis. We evaluate performance based on a number of factors; however, the primary measures of performance are the net sales, gross profit and income or loss from operations (prior to corporate allocations) of each segment, as these are the key performance indicators that we review. Operating income or loss for each segment does not include corporate general and administrative expenses, interest expense and other miscellaneous income/expense items. Corporate general and administrative expenses include, but are not limited to: human resources, legal, finance, IT, and various other corporate level activity related expenses. Such unallocated expenses remain within corporate. Corporate also includes our manufacturing assets and, accordingly, certain items associated with these activities, remain unallocated in the corporate segment. The European Retail operations are evaluated excluding the impact of any intercompany transfer pricing.

The following table represents key financial information of our business segments:

		Wholesale/ US Nutrition		North American Retail			European Retail		Direct Response/ E-Commerce		Corporate/ Manufacturing			Consolidated

*Three months ended December 31, 2008:*
	Net sales	$	406,966	$	48,438		$	156,026	$	49,122	$	—		$	660,552
	Income (loss) from operations		42,014		247			26,171		2,204		(34,426	)		36,210
	Depreciation and amortization		3,724		752			3,561		1,265		8,219			17,521
	Capital expenditures		176		1,501			4,123		4,117		12,722			22,639
*Three months ended December 31, 2007:*
	Net sales	$	258,935	$	56,182		$	158,597	$	37,144	$	—		$	510,858
	Income (loss) from operations		53,981		(864	)		35,067		7,123		(27,072	)		68,235
	Depreciation and amortization		2,694		850			3,063		1,366		5,959			13,932
	Capital expenditures		1,828		210			4,509		3		3,264			9,814

Approximately 29% and 36% of our net sales during the three months ended December 31, 2008 and 2007, respectively, were denominated in currencies other than U.S. dollars, principally British Pounds, Euros and Canadian dollars. A significant weakening of such currencies versus the U.S. dollar could have a material adverse effect on our results of operations.

Foreign subsidiaries accounted for the following percentages of total assets and total liabilities:

15. Condensed Consolidating Financial Statements of Guarantors of Senior Subordinated Notes

The 7¹/8% Senior Subordinated Notes due 2015 are guaranteed by all of our domestic subsidiaries, which are wholly-owned by the Company. These guarantees are full, unconditional and joint and several. The following condensed consolidating financial information presents:

The condensed consolidating financial statements are presented using the equity method of accounting for investments in wholly-owned subsidiaries. Under this method, the investments in subsidiaries are recorded at cost and adjusted for our share of the subsidiaries' cumulative results of operations, capital contributions, distributions and other equity changes. The principal elimination entries eliminate investments in subsidiaries and intercompany balances and transactions. This financial information should be read in conjunction with the financial statements and other notes related thereto.

15. Condensed Consolidating Financial Statements of Guarantors of Senior Subordinated Notes (Continued)

					Parent Company			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Consolidated

Assets
Current assets:
	Cash and cash equivalents				$	5,493		$	—	$	47,205		$	—		$	52,698
	Accounts receivable, net					—			120,221		25,773			(6,138	)		139,856
	Intercompany					—			87,639		625,230			(712,869	)		—
	Inventories					—			484,989		123,365			—			608,354
	Deferred income taxes					—			24,287		1,068			—			25,355
	Other current assets					—			24,919		24,773			—			49,692

				Total current assets		5,493			742,055		847,414			(719,007	)		875,955
Property, plant and equipment, net						40,060			257,399		101,969			—			399,428
Goodwill						—			184,727		139,337			—			324,064
Other intangible assets, net						—			183,015		39,487			—			222,502
Other assets						—			26,300		12,090			—			38,390
Intercompany loan receivable						289,860			40,733		—			(330,593	)		—
Investments in subsidiaries						1,905,102			—		—			(1,905,102	)		—

		Total assets			$	2,240,515		$	1,434,229	$	1,140,297		$	(2,954,702	)	$	1,860,339

Liabilities and Stockholders' Equity
Current liabilities:
	Current portion of long-term debt				$	30,745		$	1,210	$	620		$	—		$	32,575
	Accounts payable					—			102,768		32,213			—			134,981
	Intercompany					712,869			—		—			(712,869	)		—
	Accrued expenses and other current liabilities					—			138,510		36,713			(6,138	)		169,085

				Total current liabilities		743,614			242,488		69,546			(719,007	)		336,641
Intercompany loan payable						—			—		330,593			(330,593	)		—
Long-term debt, net of current portion						487,133			59		14,768			—			501,960
Deferred income taxes						28,478			—		4,153			—			32,631
Other liabilities						24,815			2,553		5,264			—			32,632

				Total liabilities		1,284,040			245,100		424,324			(1,049,600	)		903,864
Commitments and contingencies
Stockholders' Equity:
	Common stock					493			—		—			—			493
	Capital in excess of par					141,698			352,019		301,271			(653,290	)		141,698
	Retained earnings					852,543			837,110		421,728			(1,258,838	)		852,543
	Accumulated other comprehensive income					(38,259	)		—		(7,026	)		7,026			(38,259	)

				Total stockholders' equity		956,475			1,189,129		715,973			(1,905,102	)		956,475

			Total liabilities and stockholders' equity		$	2,240,515		$	1,434,229	$	1,140,297		$	(2,954,702	)	$	1,860,339

15. Condensed Consolidating Financial Statements of Guarantors of Senior Subordinated Notes (Continued)

					Parent Company		Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Consolidated

Assets
Current assets:
	Cash and cash equivalents				$	49,662	$	—	$	40,518		$	—		$	90,180
	Accounts receivable, net					—		92,396		30,482			—			122,878
	Intercompany					—		72,949		626,499			(699,448	)		—
	Inventories					—		449,128		136,111			—			585,239
	Deferred income taxes					—		24,124		974			—			25,098
	Other current assets					—		47,559		28,412			—			75,971

				Total current assets		49,662		686,156		862,996			(699,448	)		899,366
Property, plant and equipment, net						38,120		255,225		125,721			—			419,066
Goodwill						—		180,067		162,312			—			342,379
Other intangible assets, net						—		186,399		44,025			—			230,424
Other assets						—		28,584		16,539			—			45,123
Intercompany loan receivable						359,720		40,733		—			(400,453	)		—
Investments in subsidiaries						1,859,852		—		—			(1,859,852	)		—

		Total assets			$	2,307,354	$	1,377,164	$	1,211,593		$	(2,959,753	)	$	1,936,358

Liabilities and Stockholders' Equity
Current liabilities:
	Current portion of long-term debt				$	30,784	$	1,738	$	787		$	—		$	33,309
	Accounts payable					—		80,973		39,647			—			120,620
	Intercompany					699,448		—		—			(699,448	)		—
	Accrued expenses and other current liabilities					—		126,890		45,145			—			172,035

				Total current liabilities		730,232		209,601		85,579			(699,448	)		325,964
Intercompany loan payable						—		—		400,453			(400,453	)		—
Long-term debt, net of current portion						519,775		115		18,512			—			538,402
Deferred income taxes						44,109		—		5,030			—			49,139
Other liabilities						15,042		2,664		6,951			—			24,657

				Total liabilities		1,309,158		212,380		516,525			(1,099,901	)		938,162
Commitments and contingencies
Stockholders' Equity:
	Common stock					493		—		—			—			493
	Capital in excess of par					140,990		352,019		301,271			(653,290	)		140,990
	Retained earnings					839,068		812,765		408,967			(1,221,732	)		839,068
	Accumulated other comprehensive income					17,645		—		(15,170	)		15,170			17,645

				Total stockholders' equity		998,196		1,164,784		695,068			(1,859,852	)		998,196

			Total liabilities and stockholders' equity		$	2,307,354	$	1,377,164	$	1,211,593		$	(2,959,753	)	$	1,936,358

15. Condensed Consolidating Financial Statements of Guarantors of Senior Subordinated Notes (Continued)

Condensed Consolidating Statement of Income
Three Months Ended December 31, 2008

			Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated

Net sales			$	—		$	466,544		$	211,026		$	(17,018	)	$	660,552

Costs and expenses:
	Cost of sales			—			312,705			92,816			(17,018	)		388,503
	Advertising, promotion and catalog			—			25,606			5,685			—			31,291
	Selling, general and administrative			31,831			78,648			85,422			—			195,901
	IT project termination costs			—			8,647			—			—			8,647

				31,831			425,606			183,923			(17,018	)		624,342

Income from operations				(31,831	)		40,938			27,103			—			36,210

Other income (expense):
		Equity in income of subsidiaries		37,106			—			—			(37,106	)		—
		Intercompany interest		6,655			—			(6,655	)		—			—
		Interest		(9,040	)		—			(449	)		—			(9,489	)
		Miscellaneous, net		(380	)		(3,484	)		(1,769	)		—			(5,633	)

				34,341			(3,484	)		(8,873	)		(37,106	)		(15,122	)

Income before provision for income taxes				2,510			37,454			18,230			(37,106	)		21,088
(Benefit)/ provision for income taxes				(10,965	)		13,109			5,469			—			7,613

Net income			$	13,475		$	24,345		$	12,761		$	(37,106	)	$	13,475

15. Condensed Consolidating Financial Statements of Guarantors of Senior Subordinated Notes (Continued)

Condensed Consolidating Statement of Income
Three Months Ended December 31, 2007

		Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated

Net sales		$	—		$	333,069		$	198,042		$	(20,253	)	$	510,858

Costs and expenses:
	Cost of sales		—			179,426			81,158			(20,253	)		240,331
	Advertising, promotion and catalog		—			27,477			6,692			—			34,169
	Selling, general and administrative		24,474			66,673			76,976			—			168,123

			24,474			273,576			164,826			(20,253	)		442,623

Income from operations			(24,474	)		59,493			33,216			—			68,235

Other income (expense):
	Equity in income of subsidiaries		58,442			—			—			(58,442	)		—
	Intercompany interest		8,255			—			(8,255	)		—			—
	Interest		(3,544	)		(1	)		(317	)		—			(3,862	)
	Miscellaneous, net		1,143			1,993			1,751			—			4,887

			64,296			1,992			(6,821	)		(58,442	)		1,025

Income before provision for income taxes			39,822			61,485			26,395			(58,442	)		69,260
(Benefit)/ provision for income taxes			(6,000	)		21,520			7,918			—			23,438

Net income		$	45,822		$	39,965		$	18,477		$	(58,442	)	$	45,822

15. Condensed Consolidating Financial Statements of Guarantors of Senior Subordinated Notes (Continued)

Condensed Consolidating Statement of Cash Flows
Three Months Ended December 31, 2008

					Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated

Cash flows from operating activities:
	Net income				$	13,475		$	24,345		$	12,761		$	(37,106	)	$	13,475
	Adjustments to reconcile net income to net cash & cash equivalents provided by operating activities:
		Equity in earnings of subsidiaries				(37,106	)		—			—			37,106			—
		Impairments and disposals of property, plant and equipment				25			—			462			—			487
		Depreciation and amortization				1,251			12,181			4,089			—			17,521
		IT project termination costs				—			4,667			—			—			4,667
		Foreign currency transaction (gain) / loss				3,011			797			2,078			—			5,886
		Amortization of deferred charges				316			—			—			—			316
		Stock-based compensation				562			88			52			—			702
		Allowance for doubtful accounts				—			1,290			71			—			1,361
		Inventory reserves				—			1,737			—			—			1,737
		Deferred income taxes				—			153			(1	)		—			152
		Changes in operating assets and liabilities, net of acquisitions:
			Accounts receivable			—			(25,359	)		(2,381	)		—			(27,740	)
			Inventories			—			(37,759	)		(6,288	)		—			(44,047	)
			Other assets			—			5,806			(1,108	)		—			4,698
			Accounts payable			—			24,813			(200	)		—			24,613
			Accrued expenses and other liabilities			—			2,989			(105	)		—			2,884

				Net cash (used in) provided by operating activities		(18,466	)		15,748			9,430			—			6,712

Cash flows from investing activities:
	Intercompany accounts					(1,699	)		1,714			(15	)		—			—
	Purchase of property, plant and equipment					(3,190	)		(16,295	)		(3,154	)		—			(22,639	)
	Cash paid for acquisitions, net of cash acquired					—			—			(264	)		—			(264	)
	Escrow refund, net of purchase price adjustments					11,904			—			315			—			12,219

				Net cash provided by (used in) investing activities		7,015			(14,581	)		(3,118	)		—			(10,684	)

Cash flows from financing activities:
	Principal payments under long-term debt agreements and capital leases					(7,724	)		(611	)		(162	)		—			(8,497	)
	Proceeds from borrowings under the Revolving Credit Facility					35,000			—			—			—			35,000
	Principal payments under the Revolving Credit Facility					(60,000	)		—			—			—			(60,000	)
	Proceeds from stock options exercised					6			—			—			—			6

				Net cash used in financing activities		(32,718	)		(611	)		(162	)		—			(33,491	)

Effect of exchange rate changes on cash and cash equivalents						—			(556	)		537			—			(19	)

Net (decrease) increase in cash and cash equivalents						(44,169	)		—			6,687			—			(37,482	)
Cash and cash equivalents at beginning of period						49,662			—			40,518			—			90,180

Cash and cash equivalents at end of period					$	5,493		$	—		$	47,205		$	—		$	52,698

15. Condensed Consolidating Financial Statements of Guarantors of Senior Subordinated Notes (Continued)

Condensed Consolidating Statement of Cash Flows
Three Months Ended December 31, 2007

					Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated

Cash flows from operating activities:
	Net income				$	45,822		$	39,965		$	18,477		$	(58,442	)	$	45,822
	Adjustments to reconcile net income to net cash & cash equivalents provided by operating activities:
		Equity in earnings of subsidiaries				(58,442	)		—			—			58,442			—
		Impairments and disposals of property, plant and equipment				77			383			2			—			462
		Depreciation and amortization				1,546			9,019			3,367			—			13,932
		Foreign currency transaction (gain) / loss				(673	)		(911	)		285			—			(1,299	)
		Amortization of deferred charges				186			—			—			—			186
		Allowance for doubtful accounts				—			(229	)		—			—			(229	)
		Inventory reserves				—			798			263			—			1,061
		Deferred income taxes				—			449			—			—			449
		Excess income tax benefit from exercise of stock options				(88	)		—			—			—			(88	)
		Changes in operating assets and liabilities, net of acquisitions:										—
			Accounts receivable			—			(11,787	)		(2	)		—			(11,789	)
			Inventories			—			(2,252	)		(5,532	)		—			(7,784	)
			Other assets			—			3,736			(2,951	)		—			785
			Accounts payable			—			(1,724	)		2,411			—			687
			Accrued expenses and other liabilities			—			6,897			945			—			7,842

				Net cash (used in) provided by operating activities		(11,572	)		44,344			17,265			—			50,037

Cash flows from investing activities:
	Intercompany accounts					32,798			(41,152	)		8,354			—			—
	Purchase of property, plant and equipment					(2,183	)		(3,353	)		(4,278	)		—			(9,814	)
	Purchase of available-for-sale investments					(55,148	)		—			—			—			(55,148	)
	Proceeds from sale of available-for-sale investments					36,140			—			3,132			—			39,272
	Cash paid for acquisitions, net of cash acquired					(5,072	)		—			—			—			(5,072	)

				Net cash provided by (used in) investing activities		6,535			(44,505	)		7,208			—			(30,762	)

Cash flows from financing activities:
	Principal payments under long-term debt agreements and capital leases					(206	)		(33	)		—			—			(239	)
	Excess income tax benefit from exercise of stock options					88			—			—			—			88
	Purchase of treasury stock (subsequently retired)					(10,603	)		—			—			—			(10,603	)

				Net cash used in financing activities		(10,721	)		(33	)		—			—			(10,754	)

Effect of exchange rate changes on cash and cash equivalents						—			194			(2,676	)		—			(2,482	)

Net (decrease) increase in cash and cash equivalents						(15,758	)		—			21,797			—			6,039
Cash and cash equivalents at beginning of period						22,239			—			70,663			—			92,902

Cash and cash equivalents at end of period					$	6,481		$	—		$	92,460		$	—		$	98,941

NBTY, Inc.

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations

(in thousands, except per share amounts)

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this report, the words "subject to," "believe," "expect," "plan," "project," "estimate," "intend," "may," "should," "can," or "anticipate," or the negative thereof, or variations thereon, or similar expressions are intended to identify forward-looking statements, which are inherently uncertain. Similarly, discussions of strategy although believed to be reasonable, are also forward-looking statements and are inherently uncertain.

All forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from projected results. Factors which may materially affect such forward-looking statements include:

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations (Continued)

Consequently, such forward-looking statements should be regarded solely as our current plans, estimates and beliefs. Readers are cautioned not to place undue reliance on forward-looking statements. We cannot guarantee future results, events, levels of activity, performance or achievements. We do not undertake and specifically decline any obligation to update, republish or revise forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrences of unanticipated events.

Industry data used throughout this report was obtained from industry publications and internal Company estimates. While we believe such information to be reliable, its accuracy has not been independently verified and cannot be guaranteed.

The following discussion should also be read in conjunction with our condensed consolidated financial statements and notes thereto included elsewhere herein and our 2008 Form 10-K.

NBTY, Inc. (together with its subsidiaries, the "Company," "NBTY," "we," or "us") is a leading global vertically integrated manufacturer, marketer and retailer of a broad line of high quality, value-priced nutritional supplements in the United States and throughout the world. We market approximately 25,000 products under numerous brands, including Nature's Bounty®, Vitamin World®, Pure Protein®, Body Fortress®, Puritan's Pride®, Holland & Barrett®, Rexall®, Osteo Bi-Flex®,

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations (Continued)

Flex-A-Min®, Knox®, Sundown®, MET-Rx®, WORLDWIDE Sport Nutrition®, American Health®, DeTuinen®, Le Naturiste™, SISU®, Solgar®, Physiologics® and Ester-C®. Our vertical integration includes the purchase of raw materials, formulation and manufacture of products, which we then market through the following four channels of distribution:

Our significant accounting policies are described in Note 1 of the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2008. A discussion of our critical accounting policies and estimates are included in Management's Discussion and Analysis of Results of Operations and Financial Condition in our Annual Report on Form 10-K for the fiscal year ended September 30, 2008. Management has discussed the development and selection of these policies with the Audit Committee of the Company's Board of Directors, and the Audit Committee of the Board of Directors has reviewed the Company's disclosures of these policies. There have been no material changes to the critical accounting policies or estimates reported in the Management's Discussion and Analysis section of the audited financial statements for the fiscal year ended September 30, 2008 as filed with the Securities and Exchange Commission.

Operating results in all periods presented include the results of acquisitions. The timing of acquisitions and the changing mix of our businesses may affect the comparability of results from one period to another.

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations (Continued)

Three Months Ended December 31, 2008 Compared to the Three Months Ended December 31, 2007:

Net sales by segment for the three months ended December 31, 2008 as compared with the prior comparable period were as follows:

Net sales for the Wholesale / US Nutrition segment increased $148,031 or 57.2% to $406,966 for the three months ended December 31, 2008. This increase was primarily due to net sales from our newly acquired subsidiary, Leiner, which contributed $130,970 in net sales. The remaining net sales increase for the three months ended December 31, 2008 was $17,061 or 6.6%. We continue to increase sales through new product introductions and promotions. Some of the major brands in this segment include Nature's Bounty, Solgar, Osteo Bi-Flex, Rexall, Ester C and Sundown. Collectively, sales of these brands increased $3,514. Additionally, net sales from our sports nutrition brands increased $10,513 over the prior comparable quarter. We continue to adjust shelf space allocation among the US Nutrition brands to provide the best overall product mix and to respond to changing market conditions. These efforts have helped to strengthen US Nutrition's position in the mass market. US Nutrition continues to leverage valuable consumer sales information obtained from our Vitamin World retail stores and Puritan's Pride Direct Response/E-Commerce operations in order to provide its mass-market customers with data and analyses to drive mass market sales.

We continue to use targeted promotions to grow overall net sales. Promotional programs and rebates as a percentage of sales were 8.5% for the three months ended December 31, 2008 as compared to 10.1% for the prior comparable period.

Product returns were $7,508 or 1.7% of sales for the three months ended December 31, 2008 as compared to $6,638 or 2.2% of sales for the prior comparable period. The product returns for the three months ended December 31, 2008 and 2007 are mainly attributable to returns in the ordinary course of business.

One customer represented 29% and 21% of the Wholesale / US Nutrition segment's net sales for the three months ended December 31, 2008 and 2007, respectively. It also represented 18% and 10% of consolidated net sales for the three months ended December 31, 2008 and 2007, respectively. Another customer represented 12% of the Wholesale / US Nutrition segment's net sales and 7% of consolidated net sales for the three months ended December 31, 2008. The loss of either one of these

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations (Continued)

customers, or any one of our major customers, would have a material adverse effect on our results of operations if we were unable to replace such customers.

Net sales for this segment decreased $7,744 or 13.8% to $48,438 for the three months ended December 31, 2008. Sales for stores open more than one year (same store sales) decreased 11.0%. This decline in net sales is partially attributable to a shift in our Vitamin World stores strategy from reliance on promotional discounting to drive sales to an everyday low price for its customers.

The following is a summary of North American Retail store activity for the three months ended December 31, 2008 and 2007:

		Three months ended December 31,

		2008			2007
North American Retail stores:
*Vitamin World*
	Open at beginning of the period		441			457
	Opened during the period		7			2
	Closed during the period		(1	)		(5	)
	Open at end of the period		447			454
*Le Naturiste*
	Open at beginning of the period		81			80
	Opened during the period		3			—
	Closed during the period		—			—
	Open at end of the period		84			80

We anticipate opening an additional 5 Vitamin World stores and closing up to 12 under-performing Vitamin World stores during the remainder of this fiscal year.

The decrease in net sales for this segment is primarily the result of unfavorable foreign currency translation which was partially offset by an increase in net sales from the acquisition of Julian Graves. Due in part to the difficult retail environment in the U.K., local currency same store sales declined 3.4% from the prior like period. Same store sales in U.S. dollars decreased 25.8% or $40,436 as compared to the prior comparable period. This decrease was partially offset by the acquisition of Julian Graves, which contributed net sales of $35,335 for the three months ended December 31, 2008.

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations (Continued)

The following is a summary of European Retail store activity for the three months ended December 31, 2008 and 2007:

	Three months ended December 31,

	2008		2007
European Retail stores:
Company-owned stores
Open at beginning of the period		971		604
Opened during the period		5		8
Closed during the period		—		—
Open at end of the period		976		612
Franchised stores
Open at beginning of the period		22		22
Opened during the period		4		—
Closed during the period		—		—
Open at end of the period		26		22

We anticipate opening an additional 10 stores during the remainder of this fiscal year.

Direct Response/E-Commerce net sales increased $11,978 or 32.2% for the three months ended December 31, 2008 as compared to the prior comparable period. These results reflect a lowering of prices to garner greater market share in a highly competitive environment and an increase in marketing and promotional activity as compared to the prior comparable period.

The average order size increased approximately 31% for the three months ended December 31, 2008 as compared to 2007. On-line net sales comprised 47% of this segment's net sales for the three months ended December 31, 2008 as compared to 40% for 2007. We remain the vitamin and nutritional supplements leader in the direct response and e-commerce sectors and continue to increase the number of products available via our catalog and websites.

This division continues to vary its promotional strategy throughout the fiscal year, utilizing highly promotional catalogs which are not offered in every quarter. Historical results reflect this pattern and therefore this division should be viewed on an annual, and not quarterly, basis.

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations (Continued)

Gross Profit by segment for the three months ended December 31, 2008 as compared with the prior comparable period was as follows:

The Wholesale/US Nutrition segment's gross profit percentage decreased to 27.5% for the three months ended December 31, 2008 as compared to 43.9% for the prior comparable period. The three months ended December 31, 2008 includes an inventory adjustment of $2,315 relating to the fourth quarter of fiscal 2008. The decline in gross margin was mainly due to higher raw material and other manufacturing costs which were not offset by higher prices charged to customers, increased promotional activity and lower margins on Leiner private label products. Excluding Leiner, the gross profit percentage would have been 38.0% for the three months ended December 31, 2008.

The increase in the North American Retail segment's gross profit percentage to 66.9% for the three months ended December 31, 2008 as compared to 59.3% for the comparable prior period reflects a shift in promotional strategy as well as a focus on rationalizing SKU's and enhanced visual merchandising. The decrease in the European Retail segment's gross profit dollars is the result of unfavorable foreign currency translation partially offset by the acquisition of Julian Graves. The decrease in the Direct Response/E-Commerce segment's gross profit percentage to 58.8% for the three months ended December 31, 2008 as compared to 63.5% for the prior comparable period reflects the increase in promotional activity discussed under net sales above, which resulted in an increase in Direct Response/E-Commerce total gross profit dollars of $5,322 for the three months ended December 31, 2008.

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations (Continued)

Total advertising, promotion and catalog expenses by segment for the three months ended December 31, 2008 as compared with the prior comparable period were as follows:

The decrease in the Wholesale/US Nutrition segment's advertising, promotions and catalogs is due to the timing of advertising campaigns for some of our leading brands. Specifically, we incurred $2,429 less advertising for our Ester-C brand for the three months ended December 31, 2008 as compared to the prior comparable period. The increase in the prior period was the result of the launch of this recently acquired brand. We create our own advertising materials through our in-house staff of advertising associates. In the U.K. and Ireland, both Holland & Barrett and Nature's Way advertise on television and in national newspapers. GNC (UK) and De Tuinen also advertise in newspapers. SISU advertises in trade journals and magazines.

Selling, general and administrative expenses by segment for the three months ended December 31, 2008 as compared with the prior comparable period were as follows:

The Wholesale/US Nutrition's selling, general and administrative expense ("SG&A") increased $13,157 for the three months ended December 31, 2008 as compared to the prior comparable period. Freight costs increased $6,262, of which approximately $3,175 relates to the Leiner operation, and the remaining increase relates to additional shipments and higher fuel surcharges. Payroll and payroll related costs increased $3,037 primarily related to the Leiner operation. Bad debt expense increased

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations (Continued)

approximately $1,567 reflecting an increase in our accounts receivable reserves as a result of the collectability of certain accounts receivable because of the weak economic environment.

The decrease in SG&A in the North American Retail segment is the result of lower payroll and payroll related costs due to a change in the commission structure as well as lower costs incurred across most categories. In addition, the prior period included a charge of approximately $350 for asset impairments, which did not recur in the three months ended December 31, 2008.

The European Retail's SG&A increased $7,693 due to the acquisition of Julian Graves, which added $17,834 to total SG&A costs partially offset by a decrease in US dollar reported costs due to the foreign currency exchange rates. In local currency, and excluding the impact of the Julian Graves acquisition, SG&A costs increased approximately 9% due to increased occupancy expenses related to rent increases and new stores.

The Direct Response/E-Commerce SG&A increased $1,924 due to an increase in freight costs of $1,368 due to increased sales volume and higher fuel surcharges.

The Corporate segment's SG&A increased $7,335 primarily due to an increase in payroll and payroll related costs of $5,013 which includes approximately $1,500 for severance costs, in the form of stay-bonuses, associated with Leiner transitional associates.

During December 2008, management determined that certain information technology projects relating to the Direct Response segment would be terminated. As a result, $4,667 previously capitalized costs were written-off during the quarter. In addition, certain termination payments and future lease obligations of $3,415 were charged to operations during the quarter as they will not provide any future economic benefit. In connection with these terminated IT projects certain employees were also terminated resulting in a severance charge of $565.

Interest expense increased $5,627 due to interest on the $300 million Term Loan and outstanding borrowings under the Revolving Credit Facility which were not outstanding during the prior comparable period.

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations (Continued)

Miscellaneous, net decreased primarily due to unrealized foreign exchange losses on intercompany balances for the three months ended December 31, 2008 associated with the strengthening of the U.S. dollar against the British Pound and Canadian dollar as compared to unrealized foreign exchange gains in the prior comparable period as well as lower investment income earned on lower cash and investment balances.

Our provision for income taxes is impacted by a number of factors, including federal taxes, our international tax structure, state tax rates in the jurisdictions where we conduct business, and our ability to utilize state tax credits that expire between 2013 and 2016. Therefore, our overall effective income tax rate could vary as a result of these factors. The effective income tax rate for the three months ended December 31, 2008 and December 31, 2007 was 36.1% and 33.8%, respectively. The effective income tax rate was higher for the three months ended December 31, 2008 as compared to the prior comparable period due to a higher effective state rate as a result of increased operations in California from the Leiner acquisition.

Although we believe that our business is not seasonal in nature, historically, we have experienced, and expect to continue to experience, a substantial variation in our net sales and operating results from quarter to quarter. We believe that the factors that influence this variability of quarterly results include general economic and industry conditions affecting consumer spending, changing consumer demands and current news on nutritional supplements, the timing of our introduction of new products, promotional program incentives offered to customers, the timing of catalog promotions, the level of consumer acceptance of new products and actions of competitors. Accordingly, a comparison of our results of operations from consecutive periods is not necessarily meaningful, and our results of operations for any period are not necessarily indicative of future performance. Additionally, we may experience higher net sales in a quarter depending upon when we have engaged in significant promotional activities.

Our primary sources of liquidity and capital resources are cash generated from operations and our revolving credit facility. The facility provides for revolving credit loans in the aggregate principal amount of up to $325,000 to be used for working capital and other general corporate purposes, and acquisitions. At December 31, 2008, $290,000 remained undrawn on the revolving credit facility. We have used cash to finance working capital, facility expansions, acquisitions, capital expenditures and debt service requirements. We anticipate these uses will continue to be our principal uses of cash in the future.

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations (Continued)

The following table sets forth, for the periods indicated, cash balances, cash held by foreign subsidiaries and working capital:

The following table sets forth, for the period indicated, net cash flows provided by (used in) operating, investing and financing activities and other operating measures:

We monitor current and anticipated future levels of cash and cash equivalents in relation to anticipated operating, financing and investing requirements. Cash and cash equivalents held by our foreign subsidiaries are subject to U.S. income taxes upon repatriation to the U.S. We generally repatriate all earnings from our foreign subsidiaries where permitted under local law.

The decrease in working capital of $34,088 as compared to September 30, 2008 was primarily due to the paydown of long-term debt. The annualized inventory turnover rate was approximately 2.6 times during the current period ended December 31, 2008 compared to 2.5 during the prior like period. At the time of the Leiner acquisition in July 2008, Leiner inventory levels were not adequate to maintain customer fulfillment levels. The increase in inventory reflects our ongoing efforts to maintain a sufficient supply of product to respond to our increased sales levels.

Cash provided by operating activities during the three month period ended December 31, 2008 was mainly attributable to net income and non-cash charges, offset by changes in operating assets and liabilities.

During the three month period ended December 31, 2008, cash flows used in investing activities consisted primarily of purchases of property, plant and equipment, offset by an escrow refund in connection with an acquisition.

For the three month period ended December 31, 2008 cash flows used in financing activities related to the net principal payments under long-term debt agreements and principal payments under capital lease obligations.

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations (Continued)

We believe our cash generated from operations, as well as our undrawn borrowings under our $325,000 revolving credit facility, will be sufficient to fund our operations and meet our cash requirements to satisfy our working capital needs, capital expenditure needs, outstanding commitments, and other liquidity requirements associated with our existing operations over the next 18 to 24 months. Our ability to fund these requirements and comply with financial covenants under our debt agreements will depend on our future operations, performance and cash flow and is subject to prevailing economic conditions and financial, business and other factors, some of which are beyond our control. In addition, as part of our strategy, we may pursue acquisitions and investments that are complementary to our business. Any material future acquisitions or investments will likely require additional capital and, therefore, we cannot predict or assure that additional funds from existing sources will be sufficient for such future events.

We have no off-balance sheet arrangements. For additional information relating to certain contractual cash obligations see below.

We conduct retail operations under operating leases, which expire at various dates through 2031. Some of the leases contain escalation clauses, as well as renewal options, and provide for contingent rent based upon sales plus certain tax and maintenance costs. At December 31, 2008, we had $585,893 in future minimum rental payments (excluding real estate tax and maintenance costs) for retail locations and other leases that have initial or noncancelable lease terms in excess of one year.

We were committed to make future purchases for inventory related items, such as raw materials and finished goods, under various purchase arrangements with fixed price provisions aggregating $208,037 at December 31, 2008. Such purchase commitments are generally cancelable at our discretion until the order has been shipped, but require repayment of all expenses incurred through the date of cancellation. During the three months ended December 31, 2008 no one supplier individually represented greater than 10% of our raw material purchases. We do not believe that the loss of any single supplier would have a material adverse effect on our consolidated financial condition or results of operations.

We had $5,689 in open capital commitments at December 31, 2008, primarily related to manufacturing equipment as well as to computer hardware and software.

At December 31, 2008, we had $9,542 in unrecognized tax benefits, the recognition of which would have an effect of $6,364 on income tax expense and the effective income tax rate. We do not believe that the amount will change significantly in the next 12 months. At this time, we are unable to make a reasonably reliable estimate of the timing of payments in individual years beyond 12 months due to uncertainties in the timing of tax audit outcomes.

We have employment agreements with two of our executive officers. The agreements, entered into on March 1, 2008, each have a term of three years and are automatically renewed each year thereafter unless either party notifies the other to the contrary. These agreements provide for minimum salary levels and contain provisions regarding severance and change in control of the Company. The remaining commitment for salaries to these two officers as of December 31, 2008 was approximately

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations (Continued)

$3,304. In addition, five members of Holland & Barrett's senior executive staff have service contracts terminable by us upon twelve months notice. The annual aggregate commitment for such senior executive staff as of December 31, 2008 was approximately $1,300.

We maintain a consulting agreement with Rudolph Management Associates, Inc. for the services of Arthur Rudolph, one of our directors and the father of Scott Rudolph, our Chief Executive Officer. The agreement requires Mr. Rudolph to provide consulting services to us through December 31, 2009, in exchange for a consulting fee of $450 per year, payable monthly. In addition, Mr. Rudolph receives certain fringe benefits accorded to our other executives.

We have grown our business through acquisitions, and under proper conditions, may continue to seek to acquire entities in similar or complementary businesses. Such acquisitions are likely to require the incurrence and/or assumption of indebtedness and/or obligations, the issuance of equity securities or some combination thereof. In addition, we may from time to time determine to sell or otherwise dispose of certain of our existing assets or businesses; we cannot predict if any such transactions will be consummated, nor the terms or forms of consideration which might be required in any such transactions.

Inflation affects the cost of raw materials, goods and services we use. High energy costs and fluctuations in commodity prices can affect the cost of all raw materials and components. The competitive environment somewhat limits our ability to recover higher costs resulting from inflation by raising prices. However, we anticipate passing these costs to our customers, to the extent possible. We seek to mitigate the adverse effects of inflation primarily through improved productivity and strategic buying initiatives.

Our credit arrangements impose certain restrictions regarding capital expenditures and limit our ability to: incur additional indebtedness, dispose of assets, make repayments of indebtedness or amendments of debt instruments, pay distributions, create liens on assets and enter into sale and leaseback transactions, investments, loans or advances and acquisitions. Such restrictions could limit our ability to respond to market conditions, to provide for unanticipated capital investments or to take advantage of business or acquisition opportunities. We are in compliance with all covenants under our credit arrangements at December 31, 2008.

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations (Continued)

disclosures regarding an entity's derivative and hedging activities. These enhanced disclosures include information regarding how and why an entity uses derivative instruments; how derivative instruments and related hedge items are accounted for under SFAS 133, "Accounting for Derivative Instruments and Hedging Activities", and its related interpretations; and how derivative instruments and related hedge items affect an entity's financial position, financial performance and cash flows. SFAS 161 will become effective for us on October 1, 2009. The adoption of SFAS 161 will not have a material impact on our financial position, results of operations or liquidity.

NBTY, Inc.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

(in thousands)

We are subject to currency fluctuations, primarily with respect to the British pound sterling, the euro, the Canadian dollar and the Chinese yuan, and interest rate risks that arise from normal business operations. We regularly assess these risks.

We have subsidiaries whose operations are denominated in foreign currencies (primarily the British pound sterling, the euro, the Canadian dollar and the Chinese yuan). We consolidate the earnings of our international subsidiaries by translating them into U.S. dollars in accordance with Statement of Financial Accounting Standards No. 52 "Foreign Currency Translation." The statements of income of our international operations are translated into U.S. dollars at the average exchange rates in each applicable period. To the extent the U.S. dollar weakens against foreign currencies, the remeasurement of these foreign currencies denominated transactions results in increased net sales, operating expenses and net income. Similarly, our net sales, operating expenses and net income will decrease when the U.S. dollar strengthens against foreign currencies.

The U.S. dollar volume of net sales denominated in foreign currencies was approximately $192,724, or 29.2% of total net sales, for the three months ended December 31, 2008. A majority of our foreign currency exposure is denominated in the British pound sterling and Canadian dollars. For the three months ended December 31, 2008, as compared to the prior comparable period, the change in currency rates between British pound sterling and Canadian dollar as compared to the U.S. dollar was 23% and 19%, respectively, resulting in a decrease of $41,408 and $7,367 in net sales and operating income, respectively. The related impact on net income was approximately $0.15 per diluted share for the three months ended December 31, 2008.

To manage the potential risk arising from changing interest rates and their impact on long-term debt, our policy is to maintain a combination of available fixed and variable rate financial instruments. We are exposed to changes in interest rates on our floating rate revolving credit facility, our multicurrency term facility, and our $300,000 Term Loan. With respect to the interest on the Term Loan, in August 2008, we entered into two interest rate swap contracts, each with a notional amount of $100 million. Under the terms of the swap contracts, variable interest payments will be swapped for fixed interest payments. The interest rate exposure on the multicurrency term facility is mitigated by the interest earned on the cash collateral securing the loan. Therefore, a hypothetical 10% change in interest rates would not have a material effect on our consolidated pretax income or cash flow. At December 31, 2008, we had borrowings outstanding under our revolving credit facility of $35,000. A hypothetical 10% change in interest rates would not have a material effect on our consolidated pretax income or cash flow.

The 7¹/8% Senior Subordinated Notes had a fair value at December 31, 2008, based on then quoted market prices, of $133,000. At December 31, 2008, based solely on a hypothetical 10% change in interest rates related to our fixed rate Notes, we estimate that the hypothetical fair value of our fixed rate debt would have changed approximately $5,000. We believe that the carrying value of all of our other financial instruments approximates fair value due to their short maturities and variable interest rates.

Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are designed to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. Our disclosure controls and procedures are also designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officer, to allow timely decisions regarding required disclosure. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, have concluded, based on their respective evaluations as of the end of the period covered by this Report, that our disclosure controls and procedures are effective as of December 31, 2008.

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

In addition to the other information set forth in this Report, you should carefully consider the risk factors disclosed under part 1—"Item 1A. Risk Factors" in our annual report on Form 10-K for the year ended September 30, 2008, which could materially adversely affect our business, financial condition, operating results and cash flows. The risks and uncertainties described in our Form 10-K for the year ended September 30, 2008 are not the only ones we face. Risks and uncertainties not currently known to us or that we currently deem immaterial also may materially adversely affect our business, financial condition operating results or cash flows. Since September 30, 2008, there have been no significant changes relating to risk factors.

The Company sponsored Employee Stock Ownership Plan purchased 211,000 shares of our common stock at an average price per share of $14.24 in the open market during December 2008.

Exhibit No.			Description

	3.1		Restated Certificate of Incorporation of NBTY, Inc.(1)
	3.2		Amended and Restated By-Laws of NBTY, Inc.(2)
	4.1		Indenture, dated as of September 23, 2005, among NBTY, Inc., the Guarantors (as defined therein), and The Bank of New York, as Trustee(3)
	4.2		Registration Rights Agreement, dated as of September 23, 2005, among NBTY, Inc., the Guarantors (as defined therein) and J.P. Morgan Securities, Inc., Adams Harness, Inc., BNP Paribas Securities Corp., HSBC Securities (USA), Inc., and RBC Capital Markets Corporation(3)
	10.1		Executive Consulting Agreement, effective January 1, 2002, by and between NBTY, Inc. and Rudolph Management Associates, Inc.(4)
	10.2		First Amendment to Executive Consulting Agreement, effective January 1, 2003, by and between NBTY, Inc. and Rudolph Management Associates, Inc.(5)
	10.3		Second Amendment to Executive Consulting Agreement, effective January 1, 2004, by and between NBTY, Inc. and Rudolph Management Associates, Inc.(6)
	10.4		Third Amendment to Executive Consulting Agreement, effective January 1, 2005, by and between NBTY, Inc. and Rudolph Management Associates, Inc.(9)
	10.5		Fourth Amendment to Executive Consulting Agreement, effective January 1, 2006, by and between NBTY, Inc. and Rudolph Management Associates, Inc.(10)
	10.6		Fifth Amendment to Executive Consulting Agreement, effective January 1, 2007, by and between NBTY, Inc. and Rudolph Management Associates, Inc.(2)
	10.7		Sixth Amendment to Executive Consulting Agreement, effective January 1, 2008, by and between NBTY, Inc. and Rudolph Management Associates, Inc.(11)
	10.8		Seventh Amendment to Executive Consulting Agreement, effective January 1, 2009, by and between NBTY, Inc. and Rudolph Management Associates, Inc.*
	10.9		NBTY, Inc. Associate Stock Ownership Plan(12)
	10.10		NBTY, Inc. Year 2000 Incentive Stock Option Plan(7)
	10.11		NBTY, Inc. Year 2002 Stock Option Plan(8)
	10.12		NBTY, Inc. Year 2008 Stock Option Plan(13)
	10.13		Form of Incentive Stock Option Agreement pursuant to the NBTY, Inc. Year 2008 Stock Option Plan(14)
	10.14		Form of Non-Qualified Stock Option Agreement pursuant to the NBTY, Inc. Year 2008 Stock Option Plan(14)
	10.15		NBTY, Inc. Executive Bonus Plan(15)

Exhibit No.			Description

	10.16		Amended and Restated Credit Agreement, dated July 25, 2008, among NBTY, Inc., as Borrower, The Several Lenders from Time to Time Parties thereto, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, Bank of America, N.A., Citibank, N.A., HSBC Bank USA, National Association and Wachovia Bank, National Association as Co-Syndication Agents(16)
	10.17		Amended and Restated Guarantee and Collateral Agreement, by NBTY, Inc., the Guarantors party thereto in favor of JPMorgan Chase Bank, N.A., as Administrative Agent, dated as of July 25, 2008(16)
	10.18		Facility Agreement, dated September 20, 2006, for Good 'N Natural Limited with JPMorgan Chase Bank, N.A., London Branch(2)
	10.19		Novation and Amendment Agreement, dated December 18, 2007, for Good 'N Natural Limited with JPMorgan Chase Bank, N.A., London Branch and J.P. Morgan Europe Limited(17)
	10.20		Amended and Restated Asset Purchase Agreement, dated June 9, 2008, by and among NBTY Acquisition, LLC, NBTY, Inc., Leiner Health Products, Inc., Leiner Health Services, Inc. and Leiner Health Products, LLC(19)
	10.21		Employment Agreement, effective March 1, 2008, by and between NBTY, Inc. and Scott Rudolph(18)
	10.22		Employment Agreement, effective March 1, 2008, by and between NBTY, Inc. and Harvey Kamil(18)
	31.1		Rule 13a-14(a) Certification of Chief Executive Officer*
	31.2		Rule 13a-14(a) Certification of Chief Financial Officer*
	32.1		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
	32.2		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


(Mark One)
ý		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
For the quarterly period ended December 31, 2008
Or
o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
For the transition period from to


Large accelerated filer ý		Accelerated filer o		Non-accelerated filer o (Do not check if a smaller reporting company)		Smaller reporting company o

	December 31, 2008		September 30, 2008

Allowance for sales returns	$	10,057	$	8,904
Promotional programs incentive allowance		48,534		43,902
Allowance for doubtful accounts		11,440		9,768

	$	70,031	$	62,574


Accrual at September 30, 2008	$	5,849
Additional accruals		1,514
Payments		(1,296	)

Accrual at December 31, 2008	$	6,067

		December 31, 2008			September 30, 2008

Raw materials		$	180,100		$	180,330
Work-in-process			26,741			33,941
Finished goods			420,177			388,176
Valuation and obsolescence reserves			(18,664	)		(17,208	)

	Total	$	608,354		$	585,239


Delaware (State or other jurisdiction of incorporation or organization)		11-2228617 (I.R.S. Employer Identification No.)

		Page

PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	3
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Income	4
	Condensed Consolidated Statements of Stockholders' Equity and Comprehensive (Loss) Income	5
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Condensed Consolidated Financial Statements	7
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	27
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	41
Item 4.	Controls and Procedures	42
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	43
Item 1A.	Risk Factors	44
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	45
Item 6.	Exhibits	46
Signatures		49
Exhibits

	Three months ended December 31, 2007 Pro Forma

Net sales	$	640,981

Net income	$	25,225

Net income per share
Basic	$	0.38
Diluted	$	0.37
Weighted average common shares outstanding
Basic		66,903
Diluted		68,786

	Wholesale / US Nutrition			North American Retail		European Retail			Direct Response / E-Commerce		Consolidated

Balance at September 30, 2008	$	175,690		$	—	$	150,584		$	16,105	$	342,379
Foreign currency translation		(666	)		—		(25,890	)		—		(26,556	)
Purchase price adjustments		5,645			123		2,473			—		8,241

Balance at December 31, 2008	$	180,669		$	123	$	127,167		$	16,105	$	324,064

	December 31, 2008		September 30, 2008

Accrued compensation and related taxes	$	29,986	$	32,909
Accrued purchases		59,310		41,320
Litigation		10,034		10,375
Income taxes payable		3,195		11,040
Accrued interest		4,517		9,607
Other		62,043		66,784

	$	169,085	$	172,035

		Three months ended December 31,

		2008		2007
Non-cash investing and financing information:
Property, plant and equipment additions included in accounts payable		$	3,304	$	4,436
Acquisitions accounted for under the purchase method:
	Fair value of assets acquired	$	264	$	5,072
	Liabilities assumed		—		—
	Less: Cash acquired		—		—

	Net cash paid	$	264	$	5,072

			Three months ended December 31,

			2008		2007
Net sales by location of customer
	United States		$	449,191	$	303,266
	United Kingdom			147,204		148,666
	Holland			14,597		16,111
	Ireland			4,953		5,604
	Canada			22,219		9,800
	Mexico			2,779		6,235
	Other foreign countries			19,609		21,176

		Consolidated net sales	$	660,552	$	510,858

		December 31, 2008		September 30, 2008

Wholesale / US Nutrition		$	861,588	$	835,883
North American Retail			32,413		31,580
European Retail			342,656		389,794
Direct Response / E-Commerce			64,585		62,825
Corporate / Manufacturing			559,097		616,276

	Consolidated assets	$	1,860,339	$	1,936,358

		Net Sales by Segment Three months ended December 31,

		2008					2007					Comparison 2008 vs. 2007
Segment		Net Sales		% of total			Net Sales		% of total			$ change			% change
Wholesale / US Nutrition		$	406,966		61.7	%	$	258,935		50.7	%	$	148,031			57.2	%
North American Retail			48,438		7.3	%		56,182		11.0	%		(7,744	)		(13.8	)%
European Retail			156,026		23.6	%		158,597		31.0	%		(2,571	)		(1.6	)%
Direct Response / E-Commerce			49,122		7.4	%		37,144		7.3	%		11,978			32.2	%

	Net sales	$	660,552		100.0	%	$	510,858		100.0	%	$	149,694			29.3	%

		Gross Profit by Segment Three months ended December 31,

		2008					2007					Comparison 2008 vs. 2007
Segment		Gross Profit		% of sales			Gross Profit		% of sales			$ change			% change
Wholesale / US Nutrition		$	112,016		27.5	%	$	113,595		43.9	%	$	(1,579	)		(1.4	)%
North American Retail			32,419		66.9	%		33,342		59.3	%		(923	)		(2.8	)%
European Retail			98,750		63.3	%		100,048		63.1	%		(1,298	)		(1.3	)%
Direct Response / E-Commerce			28,864		58.8	%		23,542		63.5	%		5,322			22.6	%

	Gross Profit	$	272,049		41.2	%	$	270,527		53.0	%	$	1,522			0.6	%

For the fiscal year ending September 30,

2009	$	15,997
2010	$	15,746
2011	$	15,705
2012	$	15,574
2013	$	15,475

Credit Rating Agency	Secured Debt	7¹/8% Notes	Overall

Standard and Poors	BBB-	BB	BB/Stable
Moody's	Ba1/LGD3	B1/LGD6	Ba2

		Three months ended December 31,						Dollar Change			Percentage Change

		2008			2007			2008 vs. 2007			2008 vs. 2007
Wholesale / US Nutrition		$	20,683		$	23,452		$	(2,769	)		(12	)%
North American Retail			2,394			2,097			297			14	%
European Retail			3,370			3,465			(95	)		(3	)%
Direct Response / E-Commerce			4,712			5,043			(331	)		(7	)%
Corporate			132			112			20			18	%

	Total	$	31,291		$	34,169		$	(2,878	)		(8	)%

	Percentage of net sales		4.7	%		6.7	%

	As of December 31, 2008		As of September 30, 2008

Cash and cash equivalents at end of the period	$	52,698	$	90,180
Cash and cash equivalents held by foreign subsidiaries	$	47,902	$	42,172
Working capital	$	539,314	$	573,402

	For the three months ended December 31,

	2008			2007
Cash flow provided by operating activities	$	6,712		$	50,037
Cash flow used in investing activities	$	(10,684	)	$	(30,762	)
Cash flow used in financing activities	$	(33,491	)	$	(10,754	)
Inventory turnover		2.6			2.5
Days sales (Wholesale) outstanding in accounts receivable		34			40


	NBTY, INC. (Registrant)
Date: February 9, 2009	By:	/s/ SCOTT RUDOLPH Scott Rudolph Chairman and Chief Executive Officer (Principal Executive Officer)
Date: February 9, 2009	By:	/s/ HARVEY KAMIL Harvey Kamil President and Chief Financial Officer (Principal Financial and Accounting Officer)